attention%20deficit_hyperactivity%20disorder
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by the presence of impairing levels of inattention, disorganization and/or hyperactivity-impulsivity.
Symptoms that suggest ADHD include hyperactivity, acting without thinking, inattention/daydreaming, fidgety, restless, excessive talking, aggressive behavior, academic underachievement, disorganized and has difficulty in completing tasks.

Attention%20deficit_hyperactivity%20disorder Signs and Symptoms

Introduction

  • Attention deficit/hyperactivity disorder (ADHD) is a neurobehavioral disorder that is marked by a pattern of inactivity, hyperactivity and impulsivity that affects the functioning and development of a child
  • ADHD is frequently present along with  ≥1 of the following associated conditions:
    • Learning disabilities (eg cognitive impairment, specific learning disorder, motor coordination problem, memory or auditory discriminatory problems)
    • Speech and/or language delays
    • Anxiety disorder
    • Mania-bipolar disorder
    • Autistic disorder
    • Conduct disorder
    • Depression
    • Psychosis
    • Oppositional defiant disorder
    • Family and/or social problems
    • Other medical problems (eg iron deficiency, lead toxicity, Tourette’s syndrome, tics, sleep apnea)

Signs and Symptoms

  • Hyperactivity
  • Acting without thinking
  • Inattention/daydreaming
  • Fidgety, restless
  • Difficulty in completing task
  • Excessive talking
  • Aggressive behavior
  • Academic underachievement
  • Disorganized
  • Impulsive behavior
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
2 days ago
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Jairia Dela Cruz, Yesterday
The selective serotonin reuptake inhibitor escitalopram holds promise in the prevention of Alzheimer’s disease, reducing amyloid-β-42 levels in cerebrospinal fluid and brain tissue in older adults with normal cognitive function, according to recent evidence.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.